VF
SMMT icon

Virtu Financial’s Summit Therapeutics SMMT Stock Holding History

Virtu Financial’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,878
Closed -$480K – 1985
2024
Q4 		$480K Sell
26,878
-15,365
-36% -$298K 0.03% 516
2024
Q3 		$925K Buy
+42,243
New +$591K 0.05% 269
2024
Q2 		– Sell
-20,372
Closed -$84K – 1834
2024
Q1 		$84K Buy
20,372
+3,846
+23% +$15.3K 0.01% 950
2023
Q4 		$43K Buy
+16,526
New +$34K ﹤0.01% 1201
2023
Q3 		– Sell
-43,563
Closed -$109K – 1846
2023
Q2 		$109K Buy
43,563
+15,665
+56% +$28.6K 0.01% 1021
2023
Q1 		$49K Buy
27,898
+2,318
+9% +$6.32K 0.01% 1098
2022
Q4 		$109K Buy
+25,580
New +$46.5K 0.01% 926
2022
Q1 		– Sell
-13,649
Closed -$37K – 1991
2021
Q4 		$37K Buy
+13,649
New +$65.6K ﹤0.01% 1409
2021
Q1 		– Sell
-10,835
Closed -$51K – 1991
2020
Q4 		$51K Buy
+10,835
New +$45.9K 0.01% 1227
2019
Q4 		$26K Buy
+16,540
New +$26.6K ﹤0.01% 1288
2019
Q2 		– Sell
-10,751
Closed -$20K – 1827
2019
Q1 		$20K Buy
+10,751
New +$17.6K ﹤0.01% 1287
2018
Q3 		– Sell
-18,027
Closed -$44K – 2125
2018
Q2 		$44K Buy
+18,027
New +$231K ﹤0.01% 1778

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Virtu Financial's SMMT Position: Q1 2025 in Review

Virtu Financial sold out of Summit Therapeutics (SMMT) in Q1 2025, closing a stake of 26,878 shares — an estimated $480K sold.

Virtu Financial first reported a position in SMMT in Q2 2018 and held it in 12 quarters. The position peaked at $925K in Q3 2024. 212 funds tracked by Wall St. Rank hold SMMT as of Q1 2025.

  • Virtu Financial reported no remaining Summit Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 26,878 Summit Therapeutics shares in Q1 2025, an estimated $480K.
  • Virtu Financial first reported a position in Summit Therapeutics in Q2 2018 and held it in 12 quarters.
  • Virtu Financial's Summit Therapeutics position peaked at $925K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.